2020
ERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases Assembly
Ramjug S, Weatherald J, Sahay S, Khoury J, Foris V, Chandran N, Bokan A, Godinas L, Delcroix M. ERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases Assembly. ERJ Open Research 2020, 6: 00304-2020. PMID: 33083438, PMCID: PMC7553109, DOI: 10.1183/23120541.00304-2020.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsPulmonary arterial hypertensionAcute pulmonary embolismPulmonary hypertensionPulmonary embolismRisk stratificationLung diseaseEuropean Respiratory Society International CongressPulmonary vascular diseaseInterstitial lung diseaseERS International CongressESC guidelinesArterial hypertensionCardiology guidelinesPrognostic factorsVascular diseasePotential therapyFuture therapiesHypertensionNoninvasive measurePotential biomarkersRespiratory communityExciting sessionEuropean SocietyDiseaseScientific Session
2014
Alkaline phosphatase level change in patients with osteosarcoma: its role as a predictive factor of tumor necrosis and clinical outcome.
Khoury J, Ben-Arush M, Weintraub M, Waldman E, Futerman B, Vlodavsky E, Postovsky S. Alkaline phosphatase level change in patients with osteosarcoma: its role as a predictive factor of tumor necrosis and clinical outcome. Israel Medical Association Journal 2014, 16: 26-32. PMID: 24575501.Peer-Reviewed Original ResearchConceptsTumor necrosisBetter prognosisClinical outcomesPredictive factorsHistological responseBetter survivalSerum alkaline phosphatase levelsEvidence of diseaseSignificant predictive factorsAlkaline phosphatase levelsNeoadjuvant chemotherapyOverall survivalWorse survivalFemale patientsMedical filesOsteosarcoma patientsPatientsPhosphatase levelsSAP responseNecrosisFirst monthRespondersPredictive indicatorDiseaseSurvival